Adenovirus-mediated suicide gene therapy in an in vitro model of reactive gliosis

GLIA

Volumn 25, Issue 3, 1999, Pages 293-303

  Audouy, Sandrine ^a   Mallet, Jacques ^b   Privat, Alain ^a   Giménez Y Ribotta, Minerva ^a  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

Adenovirus; Astrocytes; Gene therapy; Herpes simplex thymidine kinase; Reactive gliosis

Indexed keywords

ADENOVIRUS; BROXURIDINE; EXPRESSION VECTOR; GANCICLOVIR; GENE THERAPY; GENE TRANSFER; NERVE CELL; THYMIDINE KINASE;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; ANTIVIRAL AGENTS; ASTROCYTES; AVIAN SARCOMA VIRUSES; BROMODEOXYURIDINE; CELL DIVISION; CELLS, CULTURED; CEREBRAL CORTEX; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLIOSIS; HERPES SIMPLEX; MICE; RATS; RATS, SPRAGUE-DAWLEY; THYMIDINE KINASE;

EID: 0033083716     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(19990201)25:3<293::AID-GLIA9>3.0.CO;2-G     Document Type: Article

References (78)

1. Abe-Dohmae S, Ito JI, Kato T, Tanaka R. 1990. Growth inhibition by sialosyl cholesterol of rat glioma cells. Neurochem Int 17:93-100.
2. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M, Kahn A, Peschanski MR. 1993. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 3:224-228.
3. Balzarini J, Bohman C, De Clercq E. 1993. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl) guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2. J Biol Chem 268:6332-6337.
4. Balzarini J, Morin KW, Knaus EE, Wiebe LI, De Clercq E. 1995. Novel (E)-5-(2-iodovinyl)-2'-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors. Gene Ther 2:317-322.
5. Bi WL, Parysek LM, Warnick R, Stambrook PJ. 1993. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 4:725-731.
6. Bignami A, Dahl D. 1989. Vimentin-GFAP transition in primary dissociated cultures of rat embryo spinal cord. Int J Dev Neurosci 7:343-357.
7. Bignami A, Dahl D. 1976. The astroglia response to stabbing. Immuno-fluorescence studies with antibodies to astrocyte-specific protein (GFA) in mammalian and submammalian vertebrates. Neuropathol Appl Neurol 2:99-111.
8. Bignami A Dahl, D. 1995. Gliosis. In: Kettenmann H, Ransom BR, editors. Neuroglia. New York: Oxford University Press, p 843-858.
9. Bohman C, Balzarini J, Wigerinck P, Van Aerschot A, Herdewijn P, De Clercq E. 1994. Mechanism of cytostatic action of novel 5-(thien-2-yl)- and 5-(furan-2-yl)-substituted pyrimidine nucleoside analogues against tumor cells transfected by the thymidine kinase gene of herpes simplex virus. J Biol Chem 269:8036-8043.
10. Boviatsis EJ, Chase M, Wei MX, Tamiya T, Hurford Jr, RK, Kovall NW, Tepper RI, Breakefield XO, Chiocca EA. 1994. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum Gene Ther 5:183-191.
11. Brown JO, McCough GP. 1947. Abortive regeneration of the transected spinal cord. J Comp Neurol 87:131-137.
12. Carlstedt T. 1985. Regrowth of cholinergic and catecholaminergic neurons along a peripheral and central nervous pathway. Neuroscience 15:507-518.
13. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, Klatzmann D. 1993. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 90:7024-7028.
14. Chen CY, Chang YN, Ryan P, Linscott M, Mcgarrity GJ, Chiang YL. 1995. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect." Hum Gene Ther 6:1467-1476.
15. Chen HH, Mack LM, Kelly R, Ontell M, Kochanek S, Clemens PR. 1997. Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc Nat Acad Sci USA 94:1645-1650.
16. Chen SH, Shine HD, Goodman JC, Grossman RG, Woo SLC. 1994. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 91:3054-3057.
17. Colak A, Goodman JC, Chen SH, Woo SLC, Grossman RG, Shine HD. 1995a. Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome. Brain Res 691:76-82.
18. Colak A, Goodman JC, Chen SH, Woo SLC, Grossman RG, Shine HD. 1995b. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain. Hum Gene Ther 6:1317-1322.
19. Colombo BM, Benedetti S, Ottolenghi S, Mora M, Pollo B, Poli G, Finocchiaro G. 1995. The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Ther 6:763-772.
20. Couldwell WT, Antel JP, Apuzzo MLJ, Yong VW. 1990. Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system. J Neurosurg 73:594-600.
21. Culver KW, Moorman DW, Muldoon RR, Paulsen RM, Lamsam JL, Walling HW, Link CJ. 1994. Toxicity and immunologic effects of in vivo retrovirus-mediated gene transfer of the herpes simplex-thymidine kinase gene into solid tumors. Cold Spring Harb Symp Quant Biol 59:685-690.
22. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. 1992. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256:1550-1552.
23. Culver KW, Vickers TM, Lamsam JL, Walling HW, Seregina T. 1995. Gene therapy for solid tumors. Br Med Bull 51:192-204.
24. Elion GB. 1980. The chemotherapeutic exploitation of virus-specified enzymes. Adv Enzyme Regul 18:53.
25. Freeman SM Zwiebel JA. 1993. Gene therapy of cancer. Cancer Invest 11:676-688.
26. Geisler N, Weber K. 1988. Phosphorilation of desmin in vitro inhibits formation of intermediate filaments; identification of three kinase A sites in the aminoterminal head domain. EMBO J 7:15-20.
27. Ghirnikar RS, Yu ACH, Eng LF. 1994. Astrogliosis in culture: III. Effect of recombinant retrovirus expressing antisense glial fibrillary acidic protein RNA. J Neurosci Res 38:376-385.
28. Giménez y Ribotta M, Rajaofetra N, Morin-Richaud C, Alonso G, Bochelen D, Sandillon F, Legrand A, Mersel M, Privat A. 1995. Oxysterol (7β-hydroxycholesteryl-3-oleate) promotes serotonergic reinnervation in the lesioned rat spinal cord by reducing glial reaction. J Neurosci Res 41:79-95.
29. Goldman JE, Chiu FC. 1984. Growth kinetics, cell shape, and the cytoskeleton of primary astrocyte cultures. J Neurochem 42:175-184.
30. Goodman JC, Trask TW, Chen SH, Woo SLC, Grossman RG, Carey KD, Hubbard GB, Carrier DA, Rajagopalan S, Aguilar-Cordova E, Shine HD. 1996. Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies. Hum Gene Ther 7:1241-1250.
31. Hancock MB. 1982. DAB-nickel substrate for the differential immunoperoxidase staining of nerve fibers and fiber terminals. J Histochem Cytochem 30:578.
32. Hatten ME, Liem RKH, Shelanski ML, Mason CA. 1991. Astroglia in CNS injury. Glia 4:233-243.
33. Horellou P, Vigne E, Castel MN, Barneoud P, Perricaudet M, Delaire P, Mallet J. 1995. Transplantation of cells genetically modified and direct intracerebral gene transfer with an adenoviral vector express-ing tyrosine hydroxylase in a rat model of parkinson's disease. Rest Neurol Neurosci 8:63.
34. Inagaki M, Gonda Y, Nishizawa K, Kitamura S, Sato C, Ando S, Tanabe K, Kikuchi K, Tsuiki S, Nishi Y. 1990. Phosphorilation sites linked to glial filament disassembly in vitro locate in a non-alpha-helical head domain. J Biol Chem 265:4722-4729.
35. Isacson O, Fischer W, Wictorin K, Dawbarn D, Björklund A. 1987. Astroglial response in the excitotoxically lesioned neostriatum and its projection areas in the rat. Neuroscience 20:1043-1056.
36. Ishii-Morita H, Agbaria R, Mullen CA, Hirano H, Koeplin DA, Ram Z, Oldfield EH, Johns DG, Blaese RM. 1997. Mechanism of'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment. Gene Ther 4:244-251.
37. Ito J, Kato T, Tanaka R. 1993. Mechanisms of alpha-sialosyl cholesterol action to suppress both cyclic AMP production and DNA synthesis of rat glial cells. J Neurochem 61:80-84.
38. Ito J, Masuda M, Tanaka R. 1994. Sialosylcholesterol effects on reconstitution of microfilament and glia filament. J Neurochem 62:235-239.
39. Izquierdo M, Cortes M, De Felipe P, Martin V, Diez-Guerra J, Talavera A, Pérez-Higueras A. 1995. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Ther 2:66-69.
40. Izquierdo M, Martin V, De Felipe P, Izquierdo JM, Pérez-Higueras A, Cortés ML, Paz JF, Isla A, Blázquez MG. 1996. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk/ ganciclovir gene therapy. Gene Ther 3:491-495.
41. Kramm CM, Sena-Esteves M, Barnett FH, Rainov NG, Schuback DE, Yu JS, Pechan PA, Paulus W, Chiocca EA, Breakefield XO. 1995. Gene therapy for brain tumors. Brain Pathol 5:345-381.
42. Kremer EJ, Perricaudet M. 1995. Adenovirus and adeno-associated virus mediated gene transfer. Br Med Bull 51:31-44.
43. Le Gal La Salle G, Robert JJ, Berrard S, Ridoux V, Stratford-Perricaudet L, Mallet J. 1993. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988-990.
44. Lindsay RM. 1986. Reactive gliosis, In: Fedoroff S, Vernadakis A, editors. Astrocytes. New York: Academic Press, p 231-262.
45. Liuzzi FJ, Lasek RJ. 1987. Astrocytes block axonal regeneration in mammals by activating the physiological stop pathway. Science 237:642-645,
46. Lowenstein PR, Wilkinson GWG, Castro MG, Shering AF, Fooks AR, Bain D. 1995. Non-neurotropic adenovirus: a vector for gene transfer to the brain and possible gene therapy of neurological disorders, In: Genetic manipulation of the nervous system. Latchman D, editor. New York: Academic Press, p 1-39.
47. Malhotra SK, Shnitka TK, Elbrink J 1990. Reactive astrocytes: a review. Cytobios 61:133-160.
48. Maron A, Gustin T, Leroux A, Mottet I, Dedieu JF, Brion JP, Demeure R, Perricaudet M, Octave JN. 1996. Gene therapy of rat c6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging. Gene Ther 3:315-322.
49. Maron A, Havaux N, LeRoux A, Knoops B, Perricaudet M, Octave JN. 1997. Differential toxicity of ganciclovir for rat neurons and astrocytes in primary culture following adenovirus-mediated transfer of the HSVtk gene. Gene Ther 4:25-31.
50. Matsuoka Y, Nishizawa K, Yano T, Shibata M, Ando S, Takahashi T, Inagaki M. 1992. Two different protein kinases act on a different time schedule as glial filament kinases during mitosis. EMBO J 11:2895-2902.
51. Moolten FL. 1986. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for prospective cancer control strategy. Cancer Res 46:5276-5281.
52. Moolten FL Wells, JM. 1990. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82:297-300.
53. Nathaniel EJH, Nathaniel DR. 1981. The reactive astrocyte, In: Fedoroff S, Hertz, L, editors. Advances in cellular neurobiology. New York: Academic Press, p 249-301.
54. Neve RL. 1993. Adenovirus vectors enter the brain. Trends Neurosci 16:251-253.
55. Noetzel MJ. 1990. Phosphorylation of the glial fibrillary acidic protein. J Neurosci Res 27:184-192.
56. Norton WT, Aquino DA, Hozumi I, Chiu FC, Brosnan CF. 1992. Quantitative aspects of reactive gliosis: a review. Neurochem Res 17:877-885.
57. Perez-Cruet MJ, Trask TW, Chen SH, Goodman JC, Woo SLC, Grossman RG, Shine HD. 1994. Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res 39:506-511.
58. Privat A, Giménez-Ribotta M, Ridet JL. 1995. Morphology of astrocytes. In: Kettenmann H, Ransom BR, editors. Neuroglia. New York: Oxford University Press, p 3-22.
59. Privat A, Rataboul P. 1986. Fibrous and protoplasmic astrocytes, In: Fedoroff S, Vernadakis A, editors. Astrocytes. New York: Academic Press, p 105-129.
60. Qian C, Bilbao R, Bruna O, Prieto J. 1995. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Hepatology 22:118-123.
61. Ramón y Cajal S. 1913-1914. Estudios sobre la degeneración y regeneración del sistema nervioso. Madrid: Mayo.
62. Rataboul P, Faucon Biguet N, Vernier P, De Vitry F, Boularand S, Privat A, Mallet J. 1988. Identification of a human GFAP cDNA: a tool for the molecular analysis of reactive gliosis in the mammalian CNS. J Neurosci Res 20:165-175.
63. Reier PJ. 1986. Gliosis following CNS injury: the anatomy of astrocytic scars and their influences on axonal elongation. In: Fedoroff S, Vernadakis A, editors. Astrocytes. New York: Academic Press, p 263-324.
64. Reier PJ, Eng LF, Jakeman L. 1989. Reactive astrocyte and axonal outgrowth in the injured CNS: is gliosis really an impediment to regeneration? In: Seil FJ, editor. Frontiers of clinical neuroscience: Neural regeneration and transplantation. New York: Alan R. Liss. p 183-209.
65. Reier PJ, Stensaas LJ, Guth L. 1983. The astrocytic scar as an impediment to regeneration in the central nervous system. In: Kao CC, Bunge RP, Reier PJ, editors. Spinal cord reconstruction. New York: Raven Press. p 163-196.
66. Sanes JR, Rubinstein JLR, Nicolas JF. 1986. Use of a recombinant retrovirus to study post implantation cell lineage in mouse embryos. EMBO J 5:3133-3142.
67. Shine HD Woo, SLC. 1995. Adenovirus-mediated gene therapy of tumors in the central nervous system. In: Latchman D, editor. Genetic manipulation of the nervous system. New York: Academic Press, p 53-71.
68. Stensaas LJ, Partlow LM, Burgess PR, Horch KW. 1987. Inhibition of regeneration: the ultrastructure of reactive astrocytes and abortive axon terminals in the transition zone of the dorsal root. In: Seil FJ, Herbert E, Carlson BM, editors. Progress in brain research. New York: Elsevier, p 457-467.
69. Steward O, Kelley MS, Torre ER. 1993. The process of reinnervation in the dentate gyrus of adult rats: temporal relationship between changes in the levels of glial fibrillary acidic protein (GFAP) and GFAP mRNA in reactive astrocytes. Exp Neurol 124:167-183.
70. Stratford-Perricaudet LD, Maked I, Perricaudet M, Briand P. 1992. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 90:626-630.
71. Takamiya Y, Kohsaka S, Toya S, Otani M, Tsukada Y. 1988. Immuno-histochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeletal proteins following brain injury in rats. Dev Brain Res 38:201-210.
72. Takamiya Y, Short MP, Ezzeddine ZD, Moolten FL, Breakefield XO, Martuza RL. 1992. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res 33:493-503.
73. Teramoto S, Johnson LG, Huang W, Leigh MW, Boucher RC. 1995. Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells. Hum Gene Ther 6:1045-1053.
74. Tetzlaff W, Graeber MB, Bisby MA, Kreutzberg GW. 1988. Increased glial fibrillary acidic protein synthesis in astrocytes during retrograde reaction of the rat facial nucleus. Glia 1:90-95.
75. Viola JJ, Ram Z, Walbridge S, Oshiro EM, Trapnell B, Tao-Cheng JH, Oldfield EH. 1995. Adenovirally mediated gene transfer into experi-mental solid brain tumors and leptomeningeal cancer cells. J Neurosurg 82:70-76.
76. Weinstein DE, Shelanski ML, Liem RKH. 1991. Suppression by antisense messenger RNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J Cell Biol 112:1205-1213.
77. Yu ACH, Lee YL, Eng LF. 1993. Astrogliosis in culture 1. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis. J Neurosci Res 34:295-303.
78. Yu ACH, Lee YL, Eng LF. 1991. Inhibition of GFAP synthesis by antisense RNA in astrocytes. J Neurosci Res 30:72-79.